UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.85 +0.83 (+1.06%) GOLD FUTURES
2,393.60 +33.70 (+1.43%) DOW
39,908.00 +349.89 (+0.88%) Bitcoin GBP
52,117.06 +3,558.48 (+7.33%)
Agios Pharmaceuticals, Inc. (AGIO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.94B |
| Enterprise value | 1.41B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 64.94 |
| Price/book (mrq) | 2.61 |
| Enterprise value/revenue | 47.91 |
| Enterprise value/EBITDA | -1.33 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.81 |
| 52-week change 3 | 31.41% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 35.50 |
| 52-week low 3 | 19.80 |
| 50-day moving average 3 | 30.70 |
| 200-day moving average 3 | 25.96 |
Share statistics
| Avg vol (3-month) 3 | 750.18k |
| Avg vol (10-day) 3 | 699.09k |
| Shares outstanding 5 | 56.77M |
| Implied shares outstanding 6 | 56.77M |
| Float 8 | 48.26M |
| % held by insiders 1 | 1.46% |
| % held by institutions 1 | 106.84% |
| Shares short (30 Apr 2024) 4 | 6.51M |
| Short ratio (30 Apr 2024) 4 | 9.77 |
| Short % of float (30 Apr 2024) 4 | 11.62% |
| Short % of shares outstanding (30 Apr 2024) 4 | 11.46% |
| Shares short (prior month 28 Mar 2024) 4 | 6.6M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,124.34% |
Management effectiveness
| Return on assets (ttm) | -24.55% |
| Return on equity (ttm) | -39.61% |
Income statement
| Revenue (ttm) | 29.4M |
| Revenue per share (ttm) | 0.53 |
| Quarterly revenue growth (yoy) | 46.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -386.76M |
| Net income avi to common (ttm) | -352.62M |
| Diluted EPS (ttm) | -6.31 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 597.99M |
| Total cash per share (mrq) | 10.53 |
| Total debt (mrq) | 68.35M |
| Total debt/equity (mrq) | 9.19% |
| Current ratio (mrq) | 12.84 |
| Book value per share (mrq) | 13.11 |
Cash flow statement
| Operating cash flow (ttm) | -300.75M |
| Levered free cash flow (ttm) | -221.81M |
© 2024 Yahoo. All rights reserved.